U.S. flag

An official website of the United States government

NM_000426.4(LAMA2):c.7121G>A (p.Ser2374Asn) AND LAMA2-related muscular dystrophy

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 26, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001244493.3

Allele description [Variation Report for NM_000426.4(LAMA2):c.7121G>A (p.Ser2374Asn)]

NM_000426.4(LAMA2):c.7121G>A (p.Ser2374Asn)

Gene:
LAMA2:laminin subunit alpha 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6q22.33
Genomic location:
Preferred name:
NM_000426.4(LAMA2):c.7121G>A (p.Ser2374Asn)
HGVS:
  • NC_000006.12:g.129464418G>A
  • NG_008678.1:g.586278G>A
  • NM_000426.4:c.7121G>AMANE SELECT
  • NM_001079823.2:c.7121G>A
  • NP_000417.3:p.Ser2374Asn
  • NP_001073291.2:p.Ser2374Asn
  • LRG_409t1:c.7121G>A
  • LRG_409:g.586278G>A
  • NC_000006.11:g.129785563G>A
  • NC_000006.11:g.129785563G>A
  • NM_000426.3:c.7121G>A
Protein change:
S2374N
Links:
dbSNP: rs755168390
NCBI 1000 Genomes Browser:
rs755168390
Molecular consequence:
  • NM_000426.4:c.7121G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001079823.2:c.7121G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
LAMA2-related muscular dystrophy (LAMA2-RD)
Synonyms:
Laminin alpha 2-related dystrophy
Identifiers:
MONDO: MONDO:0100228; MedGen: C5679788

Recent activity

Clear Turn Off Turn On
  • Diminished health-related quality of life
    Diminished health-related quality of life
    MedGen
  • Medulloblastoma
    Medulloblastoma
    A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs mo...<br/>
    MeSH
  • Gliosarcoma
    Gliosarcoma
    Rare mixed tumors of the brain and rarely the spinal cord which contain malignant neuroectodermal (glial) and mesenchymal components, including spindle-shaped fibrosarcoma cel...<br/>Year introduced: 1994
    MeSH
  • Thymidine Kinase
    Thymidine Kinase
    An enzyme that catalyzes the conversion of ATP and thymidine to ADP and thymidine 5'-phosphate. Deoxyuridine can also act as an acceptor and dGTP as a donor. (From Enzyme Nome...<br/>Year introduced: 1965
    MeSH
  • Fibrin
    Fibrin
    A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot.<br/>
    MeSH

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV001417718Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Uncertain significance
(Aug 26, 2021) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001417718.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces serine with asparagine at codon 2374 of the LAMA2 protein (p.Ser2374Asn). The serine residue is weakly conserved and there is a small physicochemical difference between serine and asparagine. This variant is present in population databases (rs755168390, ExAC 0.004%). This variant has not been reported in the literature in individuals affected with LAMA2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The asparagine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024